#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Dermatitis atopic Dementia Alzheimer's type Asthma Type 2 diabetes mellitus Breast cancer metastatic Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Acute graft versus host disease in liver Pneumonia Neurodevelopmental disorder Paroxysmal nocturnal haemoglobinuria Indolent systemic mastocytosis Solitary fibrous tumour Neuroendocrine cell hyperplasia of infancy Acute myeloid leukaemia Measles Polymyositis Haemophilia B without inhibitors Mycobacterium abscessus infection Non-Hodgkin's lymphoma unspecified histology indolent Cystic fibrosis respiratory infection suppression Malignant glioma More trials…

    Learn about Rare Diseases

    Extranodal marginal zone B-cell lymphoma (MALT type) Shprintzen-Goldberg syndrome – Trials in Disease MELAS syndrome – Basic Information Glomerulonephritis membranoproliferative Extranodal marginal zone B-cell lymphoma (MALT type) – Basic Information Hyperoxaluria – Life with Disease Pemphigoid Gaucher’s disease type III Nephroblastoma – Treatment Ehlers-Danlos syndrome – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Carbasalate Calcium Demeclocycline Hydrochloride Pasireotide C1 Esterase Inhibitor (Human) Fluorescein Sodium Metamizole Magnesium Gandotinib Triglycerides, Medium Chain Remifentanil Hydrochloride Valsartan Tralokinumab CIRTUVIVINT MB-CART2219.1 Ascorbic Acid VG801-2 Testosterone Trifluridine Anitocabtagene Autoleucel ABBV-8736 Omx-0407 More therapies…

    Learn about Your Condition

    Anal squamous cell carcinoma Triple negative breast cancer Pyrexia Hepatitis B Open angle glaucoma Retroperitoneal cancer Eye disorder Immunodeficiency Foot deformity Cold type haemolytic anaemia Vascular malformation Neurodegenerative disorder Thrombocytopenia Colorectal cancer stage II Thalassaemia More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Wilhelmina Childrens Hospital

Wilhelmina Childrens Hospital

Lundlaan 6, Utrecht, 3584 EA, Netherlands

Want to learn more about this study or check if you can participate? Contact us.

  • A Study of Group B Streptococcus 6-Valent Polysaccharide Conjugate Vaccine in Healthy Pregnant Women and Their Infants

    Recruiting

    3 1
    Investigated Diseases:
    • Beta haemolytic streptococcal infection
    Investigated Drugs:
    • GROUP B STREPTOCOCCUS CAPSULAR POLYSACCHARIDE IB CONJUGATED TO DIPHTHERIA TOXIN CRM197
    • STREPTOCOCCUS AGALACTIAE, SEROTYPE II, CAPSULAR POLYSACCHARIDE, CONJUGATED TO CRM197
    • STREPTOCOCCUS AGALACTIAE, SEROTYPE V, CAPSULAR POLYSACCHARIDE, CONJUGATED TO CRM197
    Finland The Netherlands Spain

  • Study of RSV vaccine and nirsevimab combination to prevent RSV infection in infants up to 12 months of age

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Respiratory syncytial virus infection
    Belgium The Netherlands

  • Study of ELA026 for Treatment of Secondary Hemophagocytic Lymphohistiocytosis in Patients with Lymphoma Who Have Not Received Previous Treatment

    Recruiting

    4 1 1
    Germany Italy The Netherlands Spain

  • Study on the Safety and Effectiveness of Bexicaserin for Seizures in Children and Adults with Developmental and Epileptic Encephalopathy

    Recruiting

    3 1
    Investigated Diseases:
    • Epileptic encephalopathy
    Belgium Finland France Germany Italy Latvia +3

  • Study of apremilast compared to placebo in children aged 5-17 years with juvenile psoriatic arthritis

    Recruiting

    3 1
    Investigated Drugs:
    • Apremilast
    Austria Belgium France Germany Greece Italy +6

  • Study on Infliximab for Children with Crohn’s Disease

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Crohn’s disease
    Investigated Drugs:
    • Infliximab
    The Netherlands

  • Study on the Safety and Effects of Radiprodil for Children with GRIN-related Disorder

    Recruiting

    3 1
    Investigated Drugs:
    • Radiprodil
    Belgium France Germany Italy The Netherlands Poland +3

  • Study on Anakinra for Children with Systemic Juvenile Idiopathic Arthritis

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Still’s disease
    • Juvenile idiopathic arthritis
    Investigated Drugs:
    • Anakinra
    The Netherlands

  • Title: Study of LP352 (bexicaserin) oral solution versus placebo for treating seizures in children and adults with Developmental and Epileptic Encephalopathies

    Not recruiting

    3 1
    Investigated Diseases:
    • Epileptic encephalopathy
    Belgium Czechia Denmark Finland France Germany +5

  • Study of emapalumab in children and adults with Macrophage Activation Syndrome (MAS) occurring in Still’s Disease or Systemic Lupus Erythematosus

    Not recruiting

    4 1 1
    Investigated Diseases:
    • Haemophagocytic lymphohistiocytosis
    Investigated Drugs:
    • Emapalumab
    Czechia Italy The Netherlands
1 2
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!